Filing Details

Accession Number:
0001127602-15-012208
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-20 17:03:00
Reporting Period:
2015-03-19
Filing Date:
2015-03-20
Accepted Time:
2015-03-20 17:03:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1318886 K Eric Rowinsky Biogen Idec Inc.
225 Binney Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-19 2,333 $59.82 13,643 No 4 M Direct
Common Stock Disposition 2015-03-19 2,333 $436.14 11,310 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-03-19 2,333 $0.00 2,333 $59.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,667 2020-03-22 No 4 M Direct
Footnotes
  1. Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Full information regarding the number of shares sold at each separate price wil be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
  3. This represents the weighted average price for shares sold at a range between $436.06 (low) and $436.15 (high).
  4. The stock options become exercisable in three (3) equal annual installments commencing one year after the grant date of 03/22/2010.